These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials. Yuan X; Du J; Liu Q; Zhang L Int J Cardiol; 2017 Feb; 228():958-966. PubMed ID: 27914358 [TBL] [Abstract][Full Text] [Related]
5. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis. Chopra V; Wesorick DH; Sussman JB; Greene T; Rogers M; Froehlich JB; Eagle KA; Saint S Arch Surg; 2012 Feb; 147(2):181-9. PubMed ID: 22351917 [TBL] [Abstract][Full Text] [Related]
6. Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review. de Waal BA; Buise MP; van Zundert AA Br J Anaesth; 2015 Jan; 114(1):44-52. PubMed ID: 25186819 [TBL] [Abstract][Full Text] [Related]
7. Perioperative statin administration with decreased risk of postoperative atrial fibrillation, but not acute kidney injury or myocardial infarction: A meta-analysis. Zhen-Han L; Rui S; Dan C; Xiao-Li Z; Qing-Chen W; Bo F Sci Rep; 2017 Aug; 7(1):10091. PubMed ID: 28855628 [TBL] [Abstract][Full Text] [Related]
8. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Mora S; Glynn RJ; Hsia J; MacFadyen JG; Genest J; Ridker PM Circulation; 2010 Mar; 121(9):1069-77. PubMed ID: 20176986 [TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Glynn RJ; Koenig W; Nordestgaard BG; Shepherd J; Ridker PM Ann Intern Med; 2010 Apr; 152(8):488-96, W174. PubMed ID: 20404379 [TBL] [Abstract][Full Text] [Related]
11. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Putzu A; Capelli B; Belletti A; Cassina T; Ferrari E; Gallo M; Casso G; Landoni G Crit Care; 2016 Dec; 20(1):395. PubMed ID: 27919293 [TBL] [Abstract][Full Text] [Related]
12. Perioperative Statins Do Not Prevent Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials. Zhao BC; Shen P; Liu KX J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2086-2092. PubMed ID: 28803772 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin and perioperative events in patients undergoing vascular surgery. Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D; N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452 [TBL] [Abstract][Full Text] [Related]
15. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. Glynn RJ; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Ridker PM N Engl J Med; 2009 Apr; 360(18):1851-61. PubMed ID: 19329822 [TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. Kouvelos GN; Arnaoutoglou EM; Matsagkas MI; Kostara C; Gartzonika C; Bairaktari ET; Milionis HJ J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):5-12. PubMed ID: 22573476 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. Yusuf S; Bosch J; Dagenais G; Zhu J; Xavier D; Liu L; Pais P; López-Jaramillo P; Leiter LA; Dans A; Avezum A; Piegas LS; Parkhomenko A; Keltai K; Keltai M; Sliwa K; Peters RJ; Held C; Chazova I; Yusoff K; Lewis BS; Jansky P; Khunti K; Toff WD; Reid CM; Varigos J; Sanchez-Vallejo G; McKelvie R; Pogue J; Jung H; Gao P; Diaz R; Lonn E; N Engl J Med; 2016 May; 374(21):2021-31. PubMed ID: 27040132 [TBL] [Abstract][Full Text] [Related]
19. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809 [TBL] [Abstract][Full Text] [Related]
20. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]